Letter comments on 'Indications for hyperthermic intraperitoneal chemotherapy (Hipec) with cytoreductive surgery: a systematic review'

Eur J Cancer. 2020 Nov:139:190-191. doi: 10.1016/j.ejca.2020.06.038. Epub 2020 Aug 15.

Authors

Mikael L Soucisse¹, Micheal Flood², Lucas Sideris³, Pierre Dubé³, Alexander Heriot²

Affiliations

¹ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Surgery, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, Quebec, Canada. Electronic address: mikael.soucisse@gmail.com.
² Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
³ Department of Surgery, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, Quebec, Canada.

PMID: 32811687
DOI: 10.1016/j.ejca.2020.06.038

No abstract available

Publication types

Letter
Comment

MeSH terms

Chemotherapy, Cancer, Regional Perfusion
Cytoreduction Surgical Procedures*
Humans
Hyperthermic Intraperitoneal Chemotherapy
Peritoneal Neoplasms* / drug therapy